Rationale and design of the CANARI study: a case-control study investigating the association between prostate cancer and 5-alpha-reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific r-Reference-Cited by-同舟云学术

Rationale and design of the CANARI study: a case-control study investigating the association between prostate cancer and 5-alpha-reductase inhibitors for symptomatic benign prostate hypertrophy by linking SNIIRAM and pathology laboratories in a specific r

Published:2017-09-14 Issue:1 Volume:32 Page:120-129
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Scailteux Lucie-Marie¹²^ORCID,Balusson Frédéric¹²,Vincendeau Sébastien³⁴,Rioux-Leclercq Nathalie⁵⁶,Nowak Emmanuel⁷⁸

Affiliation:

1. Centre Régional de Pharmacovigilance, de Pharmaco-épidémiologie et d'information sur le médicament; CHU Rennes; 2, rue Henri Le Guilloux - 35033 Rennes Cedex 9, Rennes France

2. UPRES-EA 7449 “REPERES”; Université de Rennes 1 et EHESP; 15 avenue du Professeur Léon-Bernard - CS74312 - 35043 Rennes cedex, Rennes France

3. Service d'Urologie; CHU Rennes; 2, rue Henri Le Guilloux - 35033 Rennes Cedex 9, Rennes France

4. INSERM CIC 1414; CHU de Rennes; 2, rue Henri Le Guilloux - 35033 Rennes Cedex 9, Rennes France

5. Service d'Anatomie et Cytologie Pathologiques; CHU Rennes; Université de Rennes 1; 2, rue Henri Le Guilloux - 35033 Rennes Cedex 9, Rennes France

6. IMR 1085 - IRSET; Université Rennes 1; 9 Avenue du Professeur Léon Bernard, 35000 Rennes France

7. CHU de Brest; Hôpital de La Cavale Blanche Boulevard Tanguy Prigent Brest; Finistère, Bretagne 29200 France

8. INSERM CIC 1412; IFR 148; Université de Brest; Hôpital de la Cavale Blanche Boulevard Tanguy Prigent 29200 Brest France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/fcp.12320/fullpdf

Reference29 articles.

1. Benign prostatic hyperplasia (BPH): prevalence in general practice and practical approach of French general practitioners. Results of a study based on 17,953 patients;Costa;Prog. Urol.,2004

2. Management of symptomatic BPH in France: who is treated and how?;Lukacs;Eur. Urol.,1999

3. Results of an epidemiologic surgery carried out with men 50-80 years of age to study urinary disorders, quality of life and sexual function;Richard;Prog. Urol.,2001

4. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction;Oelke;Eur. Urol.,2013

5. Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia;Descazeaud;Prog. Urol.,2015

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review;Journal of Medical Internet Research;2023-05-18

2. Development of Indirect Health Data Linkage on Health Product Use and Care Trajectories in France: Systematic Review (Preprint);2022-07-18

3. Overview of French databases available for studying anticancer drugs in real‐life setting;Fundamental & Clinical Pharmacology;2020-08-17

4. French administrative health care database (SNDS): The value of its enrichment;Therapies;2019-04

5. Major bleeding with antithrombotic agents: a 2012–2015 study using the French nationwide Health Insurance database linked to emergency department records within five areas – rationale and design of SACHA study;Fundamental & Clinical Pharmacology;2019-01-11